Meeting Banner
Abstract #1465

Voxel-Based Analysis of Early DCE-MRI Changes May Predict the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Xia Li1, Lori R. Arlinghaus1, A. Bapsi chakravarthy1, E. Brian Welch1, Jaime Farley1, Ingrid A. Mayer1, Vandana G. Abramson1, Mark C. Kelley1, Ingrid M. Meszoely1, Julie A. Means-Powell1, Ana M. Grau1, Sandeep Bhave1, Thomas E. Yankeelov1

1Vanderbilt University Institute of Imaging Science, Nashville, TN, United States

To monitor tumor response to neoadjuvant chemotherapy, investigators have begun to employ the quantitative physiological parameters available from dynamic contrast enhanced MRI (DCE-MRI). However, most studies track the changes in average parameter values obtained from the whole tumor region of interest, thereby discarding all spatial information on tumor heterogeneity. In this study, we applied a novel registration algorithm to longitudinal DCE-MRI data and performed a voxel-by-voxel analysis. The results indicate that voxel-based analysis, after longitudinal registration, may improve the ability of DCE-MRI to separate pathologic complete responders from non-responders after one cycle of therapy when using the fast exchange regime model.

Abstract PDF Poster PDF

Keywords

ability acquisition analyses applied approved available begun best bottom breast cancer chemotherapy clinical collected columns complete computing constrained contrast course cycle defined determine discarding dynamic early employ employed enhanced enrolled examine exchange extracellular fast fraction gradient heterogeneity histograms improve indicate indicating injected institute intracellular invasive investigators lead lifetime lists longitudinal maps mark matrix mayer median model molecule monitor original parametric pathologic patients perfusion permeability phys physiological predict primary quantitative rank regime registered registration residual responders response rigid scanner science segmented separate serial site slice spatial spoiled stage studies summarizing superimposed surgery table therapy thereby third throughout track trans trial tumor validated variables volume water ways yielded